Cargando…
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDSs) are bone marrow (BM) failure malignancies characterized by constitutive innate immune activation, including NLRP3 inflammasome driven pyroptotic cell death. We recently reported that the danger-associated molecular pattern (DAMP) oxidized mitochondrial DNA (ox-mtDNA)...
Autores principales: | Ward, Grace A., Dalton, Robert P., Meyer, Benjamin S., McLemore, Amy F., Aldrich, Amy L., Lam, Nghi B., Onimus, Alexis H., Vincelette, Nicole D., Trinh, Thu Le, Chen, Xianghong, Calescibetta, Alexandra R., Christiansen, Sean M., Hou, Hsin-An, Johnson, Joseph O., Wright, Kenneth L., Padron, Eric, Eksioglu, Erika A., List, Alan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966808/ https://www.ncbi.nlm.nih.gov/pubmed/36835307 http://dx.doi.org/10.3390/ijms24043896 |
Ejemplares similares
-
Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes
por: McLemore, Amy F., et al.
Publicado: (2022) -
Dual pyroptotic biomarkers predict erythroid response in lower-risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin
por: Wang, Chen, et al.
Publicado: (2021) -
Constitutively Activated DAP12 Induces Functional Anti-Tumor Activation and Maturation of Human Monocyte-Derived DC
por: Dalton, Robert, et al.
Publicado: (2021) -
S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
por: Cheng, Pinyang, et al.
Publicado: (2019) -
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
por: Sallman, David A., et al.
Publicado: (2021)